Study ID: C37440/1108
Study Title
- To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors
Teva Identifier
- C37440/1108
ClinicalTrials.gov Identifier
- NCT01922752
Study Status
- Completed
Trial Condition(s)
- Solid Tumors
Interventions
- Drug: CEP-37440
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- 07/01/2013 - 12/01/2015
Phase
- Phase 1
Study Type
Interventional